Cullinan Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Cullinan Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Cullinan Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $653M, a 32% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$653M	+$159M	+32%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$681M	+$159M	+30.5%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$449M	-$65.6M	-12.7%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$484M	-$76.9M	-13.7%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$495M	-$123M	-19.9%	Sep 30, 2023	10-Q	2023-11-08
Q2 2023	$522M	-$145M	-21.8%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$515M	+$77.5M	+17.7%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$561M	+$124M	+28.3%	Dec 31, 2022	10-K	2024-03-14
Q3 2022	$617M	+$164M	+36.1%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$667M	+$203M	+43.7%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$437M	-$42.2M	-8.8%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$437M	+$222M	+104%	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$453M			Sep 30, 2021	10-Q	2021-11-09
Q2 2021	$464M			Jun 30, 2021	10-Q	2021-08-10
Q1 2021	$480M			Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$215M			Dec 31, 2020	10-K	2022-03-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.